This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Is There Sexual Intimacy After Menopause? Canadian Women Reveal Greater Need For Physician-Women Dialogue Regarding Vaginal Health

VA - The "Hush-Hush" Condition of Menopause According to VIVA Results:

The international VIVA (Vaginal Health: Insights, Views & Attitudes) survey was commissioned by Novo Nordisk and conducted by Strategy One and obtained information from 3,520 female respondents aged 55-65 years old from Great Britain, Sweden, Denmark, Finland, Norway, the United States of America and included 500 Canadians.  The survey assessed their understanding of VA and its overall impact.  Key Canadian findings include:

  • Only seven per cent could accurately name VA as the condition that included symptoms of vaginal dryness, pain during sex, itching, burning and soreness of the vagina 1C
  • Less than half of survey respondents considered that enough information was available about the symptoms and treatment of vaginal discomfort 1D
  • Eight in ten (82 per cent) agreed VA would have a negative impact on various aspects of their life 1E
  • The majority of women surveyed agree that VA could limit their comfort of doing what they want to do, when they want to do it 1F
  • Almost three-quarters of women agree that VA can have negative consequences on a woman's sex life, followed by their ability to have a loving relationship (39 per cent) 1G
  • Over half of Canadian women surveyed lack knowledge about local estrogen therapy 7
  • Of the Canadian women surveyed, 43 per cent would consider local estrogen therapy, if it would keep their hormone levels normal 1H

For more information about vaginal atrophy, visit TheBigOw.ca.  It can't hurt!

About Novo Nordisk Canada Inc.

Novo Nordisk is a healthcare company and a world leader in diabetes care and biopharmaceuticals.  Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.  Novo Nordisk's business is driven by the Triple Bottom Line:  a commitment to economic success, environmental soundness, and social responsibility to employees and customers. For more information, visit www.novonordisk.ca.

References:

______________________________ 1 Novo Nordisk Canada Topline Report: Vaginal Health: Insights, Views and Attitudes. September 2010 2 Abstracts of Papers, Posters and Videos to be presented at the SOGC 68th Annual Clinical Meeting. Available at: http://www.sogc.org/cmes/acm2012/english/documents/2012JOGCabstractSup.pdf. Last accessed June 2012. 3 Novo Nordisk Canada Topline Report: Vaginal Health: Insights, Views and Attitudes. September 2010 4 Mayo Clinic: Vaginal Atrophy Definition. Available at: http://mayoclinic.com/health/vaginal-atrophy/DS00770. Last accessed March 2012. 5 The Big Ow- Symptoms. Available at: http://www.thebigow.ca/WhatIsTheBigOw/WhatItFeelsLike.aspx  Last accessed February 2012 6 SOGC guidelines R. E. Nappi and M. Kokot-Kierepa: Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey. 7 R. E. Nappi and M. Kokot-Kierepa: Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey.

SOURCE Novo Nordisk Canada Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,985.61 +78.99 0.47%
S&P 500 1,972.83 +9.12 0.46%
NASDAQ 4,419.0340 +27.5710 0.63%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs